H.C. Wainwright raises Revolution Medicines' target price to $350 from $280
RVMD•H.C. Wainwright raised its target price for Revolution Medicines to $350 from $280.
Related News
Wells Fargo raises Verisk Analytics target price to $265 from $260
VRSK•
IMAX Corporation: Wells Fargo cuts target price to $52 from $55
IMAX•
Needham raises Unity Software target price to $70 from $54
U•
Molson Coors Beverage Company cut to underweight from equal weight by Wells Fargo
TAP•
Delek Logistics Q3 revenue beats analyst expectations
DKL•